一个更新的小分子化合物针对癌症治疗的合成致死性针对癌症治疗
Jiaxiang Luo1, Yang Li1, Yiwen Zhang1
1Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy and Department of Pulmonary and Critical Care Medicine, Institute of Respiratory Health and Frontiers Science Center for Disease-related Molecular Network and Laboratory of Neuro-system and Multimorbidity, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.
European journal of medicinal chemistry
|September 6, 2024
概括
合成致死性 (SL) 针对癌症的脆弱性. 新的小分子抑制剂正在开发中,以利用SL用于精确的癌症疗法,优化功效和特异性.
科学领域:
- 在瘤学瘤学.
- 药用化学 医学化学
- 遗传学 是一个遗传学.
背景情况:
- 合成致死性 (SL) 是一种精确的瘤学策略,针对癌症特定的脆弱性.
- PARP 抑制剂是基于SL的成功癌症治疗的典范.
- 在DNA损伤反应 (DDR) 的进步揭示了新的SL基因对.
研究的目的:
- 审查最近的药物化学进展,设计用于SL的小分子抑制剂.
- 突出BRCA-PARP以外的新兴SL目标,包括ATR,ATM和DNA-PK.
- 讨论优化用于癌症治疗的SL药物的挑战和机会.
主要方法:
- 关于SL的药物化学和合理药物设计的最新文献的综述.
- 分析新兴的SL目标及其在癌症治疗中的潜力.
- 讨论小分子抑制剂开发的功效,特异性和类似药物的特性.
主要成果:
- 在DNA损伤反应途径中识别新型SL基因对.
- 开发针对关键SL基因的选择性小分子抑制剂.
- 在优化药物特性以获得临床疗效方面,仍然存在挑战.
结论:
- 针对合成致死性为精确的癌症治疗提供了一个有希望的途径.
- 小分子抑制剂的合理设计对于在癌细胞中引起SL至关重要.
- 基于SL的药物设计的进一步创新可能会打开新的治疗前景.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targets for Drug Action: Overview
6.1K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.1K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Drugs that Destabilize Microtubules
1.9K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
1.9K
Protein Networks
3.9K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.9K


